Autologous cartilage micrografting
Mytocel MSK. Prepared from the patient’s own cartilage, at the point of care.
Mytocel MSK® is supplied to UK clinics exclusively by Actomed. Choose the information written for you.
For healthcare professionals
Product, procedure, evidence, clinic setup and UK supply.
- Documented indications and patient selection
- Every study linked in full, with its design and limitations
- Structured onboarding and first-case support
For patients and carers
What it is, what to expect, and how to find a clinic.
- Plain-English explanation of the treatment
- What the studies found, honestly
- UK clinics that can arrange an assessment
Manufacturer
Manufactured by Human Brain Wave srl, Turin, Italy, part of the Remedi group. Registered with the MHRA. Registration is not approval.
UK partner
Actomed is the exclusive UK supplier of Mytocel MSK, holding stock of Rigeneracons® RS and supporting N4SA installation.
Evidence
Every study behind Mytocel MSK is listed in full on both sections, with its design and its limits.
The system
Two devices, one point-of-care processing cycle.
